Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

Nuno R. Faria(Universidade de São Paulo), Thomas A. Mellan(Imperial College London), Charles Whittaker(Imperial College London), Ingra Morales Claro(Universidade de São Paulo), Darlan da Silva Cândido(Universidade de São Paulo), Swapnil Mishra(Imperial College London), Myuki Alfaia Esashika Crispim(Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas), Flavia Cristina da Silva Sales(Universidade de São Paulo), Iwona Hawryluk(Imperial College London), John T. McCrone(University of Edinburgh), Ruben J. G. Hulswit(Centre for Human Genetics), Lucas Augusto Moysés Franco(Universidade de São Paulo), Mariana Severo Ramundo(Universidade de São Paulo), Jaqueline Góes de Jesus(Universidade de São Paulo), Pâmela dos Santos Andrade(Departamento de Epidemiología), Thaís de Moura Coletti(Universidade de São Paulo), Giulia Magalhães Ferreira(Universidade Federal de Uberlândia), Camila Alves Maia da Silva(Universidade de São Paulo), Erika R. Manuli(Universidade de São Paulo), Rafael H. M. Pereira(Institute of Applied Economic Research), Pedro S. Peixoto(Universidade de São Paulo), Moritz U. G. Kraemer(University of Oxford), Nelson Gaburo, Cecilia da C. Camilo, Henrique Hoeltgebaum(Imperial College London), William Marciel de Souza(Universidade de São Paulo), E Rocha(Universidade de São Paulo), L. M. de S. e Souza(Universidade de São Paulo), Mariana C. Pinho(Universidade de São Paulo), Leonardo José Tadeu de Araújo(Instituto Adolfo Lutz), Frederico Scott Varella Malta, Aline Brito de Lima, Joice do Prado Silva, Danielle Alves Gomes Zauli, Alessandro Clayton de Souza Ferreira, Ricardo Parolin Schnekenberg(University of Oxford), Daniel J. Laydon(Imperial College London), Patrick Walker(Imperial College London), Hannah M. Schlüter(Imperial College London), Ana L. P. dos Santos(Centro Universitário Lusíada), Maria S. Vidal(Centro Universitário Lusíada), Valentina S. Del(Centro Universitário Lusíada), Rosinaldo M. F. Filho(Centro Universitário Lusíada), Helem M. dos Santos(Centro Universitário Lusíada), Renato Santana Aguiar(Universidade Federal de Minas Gerais), José Luiz Proença‐Módena(Universidade Estadual de Campinas (UNICAMP)), Bruce Nelson(Instituto Nacional de Pesquisas da Amazônia), James A. Hay(Center for Disease Dynamics, Economics & Policy), Mélodie Monod(Imperial College London), Xenia Miscouridou(Imperial College London), Helen Coupland(Imperial College London), Raphael Sonabend(Imperial College London), Michaela Vollmer(Imperial College London), Axel Gandy(Imperial College London), Carlos A. Prete(Universidade de São Paulo), Vítor H. Nascimento(Universidade de São Paulo), Marc A. Suchard(University of California, Los Angeles), Thomas A. Bowden(Centre for Human Genetics), Sergei L. Kosakovsky Pond(Temple University), Chieh‐Hsi Wu(University of Southampton), Oliver Ratmann(Imperial College London), Neil M. Ferguson(Imperial College London), Christopher Dye(University of Oxford), Nicholas J. Loman(University of Birmingham), Philippe Lemey(Rega Institute for Medical Research), Andrew Rambaut(University of Edinburgh), Nelson Abrahim Fraiji(Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas), Maria do P. S. S. Carvalho(Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas), Oliver G. Pybus(Royal Veterinary College), Seth Flaxman(Imperial College London), Samir Bhatt(University of Copenhagen), Éster Cerdeira Sabino(Universidade de São Paulo)
Science
April 14, 2021
Cited by 1,538Open Access
Full Text

Abstract

Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Manaus, Brazil, resurged in late 2020 despite previously high levels of infection. Genome sequencing of viruses sampled in Manaus between November 2020 and January 2021 revealed the emergence and circulation of a novel SARS-CoV-2 variant of concern. Lineage P.1 acquired 17 mutations, including a trio in the spike protein (K417T, E484K, and N501Y) associated with increased binding to the human ACE2 (angiotensin-converting enzyme 2) receptor. Molecular clock analysis shows that P.1 emergence occurred around mid-November 2020 and was preceded by a period of faster molecular evolution. Using a two-category dynamical model that integrates genomic and mortality data, we estimate that P.1 may be 1.7- to 2.4-fold more transmissible and that previous (non-P.1) infection provides 54 to 79% of the protection against infection with P.1 that it provides against non-P.1 lineages. Enhanced global genomic surveillance of variants of concern, which may exhibit increased transmissibility and/or immune evasion, is critical to accelerate pandemic responsiveness.


Related Papers

No related papers found

Powered by citation graph analysis